// App-Quantinova.ai

e18559 : Incidence of venous thromboembolic events (VTE) in multiple myeloma patients receiving lenalidomide (LEN) with and without dexamethasone (DEX).

Researchers

Presenter

  • Nancy A. Brandenburg

Principal Investigators

  • Tyler Knight

  • Kathryn P. Anastassopoulos

  • Neil Minton

  • Robert D. Knight

Medical Centers

  • Covance Market Access Services, San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Multiple Myeloma

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved